Print
Email
Share

Venezuela aims to annul patents for antibiotic

Associated Press

Posted on November 21, 2009 at 10:01 PM

CARACAS, Venezuela (AP) — Venezuela's trade minister says the government plans to annul the pharmaceutical patents for an antibiotic produced by Bayer HealthCare.

The Venezuelan Trade Ministry said in a statement that the government has begun a process to invalidate the patents after being alerted by the country's generic drug laboratories that Bayer is taking legal actions against those producing the antibiotic moxifloxacin.

Trade Minister Eduardo Saman announced the decision Friday. His agency said in a statement that authorities determined there were procedural problems in the granting of the patents in 1994 and 2000.

There was no immediate reaction from Bayer HealthCare, which is a unit of German drug and chemical company Bayer AG.

Print
Email
Share

Forgot Password?

Don't have an account?

Register Now

Member Benefits

Link your account to your Twitter or Facebook account for easier login!

Link your account to your Facebook profile Link your account to your Twitter profile

Check box to receive Free Special Offers

* - Indicates required field

Check box to receive Free Special Offers

Connecting to

You may need to allow pop up window for this step of registration

Just one more step:

Please take a moment to review the available e-mail newsletters has to offer. Place a checkbox next to the newsletters you wish to subscribe to.

Welcome.

Thank you for becoming a member of fox11az.com. You now have full access to the best local coverage and late breaking news from fox11az.com. Soon you will be redirected to the page you were seeking, and a confirmation email will be delivered to you.

You will need to respond to the confirmation e-mail for your account to be activated.

fox11az.com is dedicated to bringing you exceptional news and outstanding information services, all while personalizing it to your liking. We're sure you'll enjoy being a fox11az.com member! If you need assistance, please contact us.